AMGN
$276.49
Revenue | $9167Mn |
Net Profits | $1432Mn |
Net Profit Margins | 15.62% |
Amgen Inc.’s revenue jumped 9.29% since last year same period to $9167Mn in the Q2 2025. On a quarterly growth basis, Amgen Inc. has generated 12.49% jump in its revenue since last 3-months.
Amgen Inc.’s net profit jumped 91.96% since last year same period to $1432Mn in the Q2 2025. On a quarterly growth basis, Amgen Inc. has generated -17.23% fall in its net profits since last 3-months.
Amgen Inc.’s net profit margin jumped 75.64% since last year same period to 15.62% in the Q2 2025. On a quarterly growth basis, Amgen Inc. has generated -26.42% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 5.02 |
EPS Estimate Current Year | 5.02 |
Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 5.02 - a -4.92% fall from last quarter’s estimates.
Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 5.02.
Earning Per Share (EPS) | 6.02 |
Dividend Per Share (DPS) | 2.38 |
Amgen Inc.’s earning per share (EPS) jumped 21.13% since last year same period to 6.02 in the Q2 2025. This indicates that the Amgen Inc. has generated 21.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Amgen Inc. declared 2.38 dividend per share during the earnings announcement for Q2 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-08-06 | 5.28 | 6.02 | 14.02% |
2025-05-02 | 4.26 | 4.9 | 15.02% |